Literature DB >> 21651507

Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.

Caterina P Minniti, Jonathan Wilson, Laurel Mendelsohn, Greg C Rigdon, Jonathan W Stocker, Alan T Remaley, Gregory J Kato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21651507      PMCID： PMC3215801          DOI： 10.1111/j.1365-2141.2011.08757.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Authors:  Kenneth I Ataga; Wally R Smith; Laura M De Castro; Paul Swerdlow; Yogen Saunthararajah; Oswaldo Castro; Elliot Vichinsky; Abdullah Kutlar; Eugene P Orringer; Greg C Rigdon; Jonathan W Stocker
Journal:  Blood       Date:  2008-01-11       Impact factor: 22.113

2.  Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.

Authors:  Armand Mekontso Dessap; Rusel Leon; Anoosha Habibi; Ruben Nzouakou; Françoise Roudot-Thoraval; Serge Adnot; Bertrand Godeau; Frederic Galacteros; Christian Brun-Buisson; Laurent Brochard; Bernard Maitre
Journal:  Am J Respir Crit Care Med       Date:  2008-01-03       Impact factor: 21.405

Review 3.  Natriuretic peptides.

Authors:  E R Levin; D G Gardner; W K Samson
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

4.  N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.

Authors:  Galila M Mokhtar; Amira A M Adly; Mohsen S El Alfy; Lamis M Tawfik; Ahmed T Khairy
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

5.  Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Russell P Rother; Xunde Wang; Sidney M Morris; Kerry Quinn-Senger; Richard Kelly; Stephen J Richards; Monica Bessler; Leonard Bell; Peter Hillmen; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-03-08       Impact factor: 6.998

6.  Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).

Authors:  Kenneth I Ataga; Marvin Reid; Samir K Ballas; Zahida Yasin; Carolyn Bigelow; Luther St James; Wally R Smith; Frederic Galacteros; Abdullah Kutlar; James H Hull; Jonathan W Stocker
Journal:  Br J Haematol       Date:  2011-02-17       Impact factor: 6.998

7.  N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Authors:  Roberto F Machado; Anastasia Anthi; Martin H Steinberg; Duane Bonds; Vandana Sachdev; Gregory J Kato; Angelo M Taveira-DaSilva; Samir K Ballas; William Blackwelder; Xiuli Xu; Lori Hunter; Bruce Barton; Myron Waclawiw; Oswaldo Castro; Mark T Gladwin
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

8.  Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension.

Authors:  Eduard J van Beers; Erfan Nur; Cornelia M Schaefer-Prokop; Melvin R Mac Gillavry; Joost W J van Esser; Dees P M Brandjes; Maria C Kappers-Klunne; Ashley J Duits; Frits A J Muskiet; John-John B Schnog; Bart J Biemond
Journal:  Am J Hematol       Date:  2008-11       Impact factor: 10.047

9.  Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea.

Authors:  Matthew Olnes; Amy Chi; Carissa Haney; Rose May; Caterina Minniti; James Taylor; Gregory J Kato
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

10.  Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.

Authors:  Ersi Voskaridou; George Tsetsos; Antonios Tsoutsias; Evgenia Spyropoulou; Dimitrios Christoulas; Evangelos Terpos
Journal:  Haematologica       Date:  2007-06       Impact factor: 9.941
  10 in total
  3 in total

Review 1.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

2.  The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.

Authors:  Mehdi Nouraie; Janet S Lee; Yingze Zhang; Tamir Kanias; Xuejun Zhao; Zeyu Xiong; Timothy B Oriss; Qilu Zeng; Gregory J Kato; J Simon R Gibbs; Mariana E Hildesheim; Vandana Sachdev; Robyn J Barst; Roberto F Machado; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; Jonathan C Goldsmith; Victor R Gordeuk; Mark T Gladwin
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

3.  Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.

Authors:  Latha Paka; David E Smith; Dawoon Jung; Siobhan McCormack; Ping Zhou; Bin Duan; Jing-Song Li; Jiaqi Shi; Yong-Jie Hao; Kai Jiang; Michael Yamin; Itzhak D Goldberg; Prakash Narayan
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.